These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 36588548)

  • 1. Association of QT interval-prolonging drugs with clinical trial eligibility in patients with advanced cancer.
    Rowe EJ; Shugg T; Ly RC; Philips S; Rosenman MB; Callaghan JT; Radovich M; Overholser BR; Schneider BP; Tisdale JE; Skaar TC
    Front Cardiovasc Med; 2022; 9():894623. PubMed ID: 36588548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. QTc Interval-Prolonging Medications Among Patients With Lung Cancer: Implications for Clinical Trial Eligibility and Clinical Care.
    Le T; Yang H; Rashdan S; Link MS; Zaha VG; Alvarez C; Gerber DE
    Clin Lung Cancer; 2020 Jan; 21(1):21-27.e5. PubMed ID: 31780402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and outcomes of long QTc in acute medical admissions.
    Mahmud R; Gray A; Nabeebaccus A; Whyte MB
    Int J Clin Pract; 2018 Nov; 72(11):e13250. PubMed ID: 30222237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of QT interval prolongation in patients admitted to cardiac care units and frequency of subsequent administration of QT interval-prolonging drugs: a prospective, observational study in a large urban academic medical center in the US.
    Tisdale JE; Wroblewski HA; Overholser BR; Kingery JR; Trujillo TN; Kovacs RJ
    Drug Saf; 2012 Jun; 35(6):459-70. PubMed ID: 22612851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methadone maintenance, QTc and torsade de pointes: who needs an electrocardiogram and what is the prevalence of QTc prolongation?
    Mayet S; Gossop M; Lintzeris N; Markides V; Strang J
    Drug Alcohol Rev; 2011 Jul; 30(4):388-96. PubMed ID: 21355918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical toxicologists' practice patterns regarding drug-induced QT prolongation in overdose patients: a survey in the United States of America, Europe, and Asia Pacific region.
    Othong R; Devlin JJ; Kazzi ZN
    Clin Toxicol (Phila); 2015 May; 53(4):204-9. PubMed ID: 25706450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for prolonged QTc among US adults: Third National Health and Nutrition Examination Survey.
    Benoit SR; Mendelsohn AB; Nourjah P; Staffa JA; Graham DJ
    Eur J Cardiovasc Prev Rehabil; 2005 Aug; 12(4):363-8. PubMed ID: 16079644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combinations of QTc-prolonging drugs: towards disentangling pharmacokinetic and pharmacodynamic effects in their potentially additive nature.
    Meid AD; Bighelli I; Mächler S; Mikus G; Carrà G; Castellazzi M; Lucii C; Martinotti G; Nosè M; Ostuzzi G; Barbui C; Haefeli WE
    Ther Adv Psychopharmacol; 2017 Dec; 7(12):251-264. PubMed ID: 29201344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Common Genetic Variant Risk Score Is Associated With Drug-Induced QT Prolongation and Torsade de Pointes Risk: A Pilot Study.
    Strauss DG; Vicente J; Johannesen L; Blinova K; Mason JW; Weeke P; Behr ER; Roden DM; Woosley R; Kosova G; Rosenberg MA; Newton-Cheh C
    Circulation; 2017 Apr; 135(14):1300-1310. PubMed ID: 28213480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of a clinical decision support system for reducing the risk of QT interval prolongation in hospitalized patients.
    Tisdale JE; Jaynes HA; Kingery JR; Overholser BR; Mourad NA; Trujillo TN; Kovacs RJ
    Circ Cardiovasc Qual Outcomes; 2014 May; 7(3):381-90. PubMed ID: 24803473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computer-assisted interventions to improve QTc documentation in patients receiving QT-prolonging drugs.
    Sandau KE; Sendelbach S; Fletcher L; Frederickson J; Drew BJ; Funk M
    Am J Crit Care; 2015 Mar; 24(2):e6-e15. PubMed ID: 25727282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and determinants of QT interval prolongation in medical inpatients.
    Pasquier M; Pantet O; Hugli O; Pruvot E; Buclin T; Waeber G; Aujesky D
    Intern Med J; 2012 Aug; 42(8):933-40. PubMed ID: 21299787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of a risk score to predict QT interval prolongation in hospitalized patients.
    Tisdale JE; Jaynes HA; Kingery JR; Mourad NA; Trujillo TN; Overholser BR; Kovacs RJ
    Circ Cardiovasc Qual Outcomes; 2013 Jul; 6(4):479-87. PubMed ID: 23716032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk Factors for QT Prolongation in Patients with Chronic Hydroxychloroquine Use.
    Liao Y; Liu PY; Huang MS; Mau YL; Su PF; Huang TC
    Acta Cardiol Sin; 2022 Nov; 38(6):723-735. PubMed ID: 36440249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. QT Prolongation in Cancer Patients.
    Kim P; Masha L; Olson A; Iliescu C; Karimzad K; Hassan S; Palaskas N; Durand JB; Leung CH; Lopez-Mattei J
    Front Cardiovasc Med; 2021; 8():613625. PubMed ID: 33718445
    [No Abstract]   [Full Text] [Related]  

  • 16. QT interval prolongation and the risk of torsades de pointes: essentials for clinicians.
    Trinkley KE; Page RL; Lien H; Yamanouye K; Tisdale JE
    Curr Med Res Opin; 2013 Dec; 29(12):1719-26. PubMed ID: 24020938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for QTc interval prolongation.
    Heemskerk CPM; Pereboom M; van Stralen K; Berger FA; van den Bemt PMLA; Kuijper AFM; van der Hoeven RTM; Mantel-Teeuwisse AK; Becker ML
    Eur J Clin Pharmacol; 2018 Feb; 74(2):183-191. PubMed ID: 29167918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-Throughput Assessment of Real-World Medication Effects on QT Interval Prolongation: Observational Study.
    Yuan N; Oesterle A; Botting P; Chugh S; Albert C; Ebinger J; Ouyang D
    JMIR Cardio; 2023 Jan; 7():e41055. PubMed ID: 36662566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New Generation Antipsychotic Drugs and QTc Interval Prolongation.
    Vieweg WV
    Prim Care Companion J Clin Psychiatry; 2003 Oct; 5(5):205-215. PubMed ID: 15213787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drugs and ventricular repolarization in a general population: the Rotterdam Study.
    Niemeijer MN; van den Berg ME; Franco OH; Hofman A; Kors JA; Stricker BH; Eijgelsheim M; Rijnbeek PR
    Pharmacoepidemiol Drug Saf; 2015 Oct; 24(10):1036-41. PubMed ID: 26248883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.